FDA Adverse Event Injury Summary report: N

SYNERGY

MDR report key: 10380852 · Received August 7, 2020

Report

Report Number
2134265-2020-09975
Event Type
Injury
Date Received
August 7, 2020
Date of Event
July 17, 2020
Report Date
August 7, 2020
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
NIQ
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

IT WAS REPORTED THAT STENT DAMAGE POST-DEPLOYMENT OCCURRED. THE 85-90% STENOSED TARGET LESION WAS LOCATED IN THE MILDLY TORTUOUS AND SEVERELY CALCIFIED LEFT ANTERIOR DESCENDING ARTERY (LAD) AND RIGHT CORONARY ARTERY (RCA) WITH HEAVILY DISEASED POSTEROLATERAL ARTERY BRANCH (PLB). A NON-BSC WIRE WAS ADVANCED INTO POSTERIOR DESCENDING ARTERY (PDA) FROM RCA AND A 1.5MM ROTAPRO WAS USED TO SUCCESSFULLY ABLATE CALCIUM IN PROXIMAL TO MID RCA AND WAS TREATED WITH A WOLVERINE CUTTING BALLOON. A 2.5X48MM SYNERGY DRUG-ELUTING STENT (DES) WAS ADVANCED FOR TREATMENT IN THE PDA AND DISTAL RCA, A 3.5X48MM SYNERGY DES IN THE MID RCA AND A 4X20MM SYNERGY DES IN THE PROXIMAL RCA. ALL STENTS WERE POST DILATED WITH NC EMERGE BALLOON CATHETERS. SUBSEQUENTLY, A NON-BSC GUIDEWIRE WAS ADVANCED THROUGH THE CELLS AT THE BIFURCATION/OSTIUM OF THE PLB AND A 6F GUIDEZILLA II CATHETER-GUIDE WAS USED TO PROVIDE ADDITIONAL SUPPORT AS THERE WERE HAVING ISSUE PASSING THE BALLOONS FOR DILATION. A 2.25X28MM SYNERGY DES WAS ATTEMPTED TO CROSS THE CELL OF THE IMPLANTED 2.5X48MM SYNERGY DES BUT FAILED. THE DEVICE WAS REMOVED AND AFTER MORE DILATATIONS IT WAS SUCCESSFULLY POSITIONED IN THE PLB. HOWEVER, UNDER ANGIOGRAPHY, IT WAS NOTICED THAT THE 2.5X48MM SYNERGY DES WAS DAMAGED AFTER CROSSING BIFURCATION CELL WITH 2.5X28 SYNERGY DES. THE CONTRALATERAL SIDE WALL OF THE STENT WAS RAISED FROM THE WALL. THE 2.5X28MM SYNERG DES WAS REMOVED AND TREAT THE PLB WITH A NON-BSC DRUG-COATED BALLOON AND THE DAMAGED IMPLANTED STENT WAS REPAIRED USING A NC EMERGE POST-DILATION BALLOON. THE PROCEDURE WAS COMPLETED AND NO PATIENT COMPLICATIONS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
844126 SYNERGY CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC CORPORATION 10632 0024486712

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention GUIDE WIRE: GUIDEZILLA II 6F| STENT: 2.5X28 SYNERGY DRUG-ELUTING STENT